Related Experiment Video

Updated: Jul 14, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Suppression of complement regulatory protein C1 inhibitor in vascular endothelial activation by inhibiting vascular

Haimou Zhang1, Gangjian Qin, Gang Liang

  • 1Center for Infection and Immunity Research, School of Life Sciences, Hubei University, Wuhan, Hubei, PR China.

Biochemical and Biophysical Research Communications
|May 25, 2007
PubMed

Insights

Complement regulatory protein C1 inhibitor (C1INH) prevents endothelial cell injury and blocks leukocyte adhesion. C1INH suppresses vascular cell adhesion molecule-1 (VCAM-1) expression by inhibiting NF-kappaB activation, offering therapeutic potential for vascular inflammation.

Area of Science:

  • Immunology
  • Vascular Biology
  • Molecular Medicine

Background:

  • Activated endothelium expresses adhesion molecules, a key feature of vascular inflammation in diseases like sepsis.
  • Endothelial cell injury is a critical pathological event in sepsis and endotoxin shock.
  • Complement regulatory protein C1 inhibitor (C1INH) has demonstrated protective effects against endothelial cell injury.

Purpose of the Study:

  • To investigate the hypothesis that C1INH possesses anti-endothelial activation properties.
  • To determine if C1INH suppresses the expression of adhesion molecules.
  • To elucidate the molecular mechanisms underlying C1INH's effects on endothelial activation.

Main Methods:

  • Assessed C1INH's effect on leukocyte adhesion to endothelial cells under static and flow conditions.
  • Quantified vascular cell adhesion molecule-1 (VCAM-1) expression and mRNA levels in inflammatory conditions.
  • Investigated the impact of C1INH on NF-kappaB activation, IkappaBalpha degradation, and IkappaB kinase activity.

Main Results:

  • C1INH effectively blocked leukocyte adhesion to endothelial cell monolayers.
  • C1INH significantly reduced VCAM-1 expression, affecting both mRNA stability and nuclear transcription.
  • C1INH suppressed NF-kappaB activation and nuclear translocation in an IkappaBalpha-dependent manner, reducing IkappaB kinase activity.

Conclusions:

  • C1INH plays a novel role in inhibiting vascular endothelial activation.
  • C1INH's mechanism involves the suppression of VCAM-1 expression via the NF-kappaB pathway.
  • These findings suggest C1INH as a potential therapeutic agent for inflammatory vascular diseases.

More Related Videos

Quantitation of Endothelial Cell Adhesiveness In Vitro10:24

Quantitation of Endothelial Cell Adhesiveness In Vitro

Published on: June 18, 2015

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood07:08

Assessment of the Anticoagulant and Anti-inflammatory Properties of Endothelial Cells Using 3D Cell Culture and Non-anticoagulated Whole Blood

Published on: September 5, 2017

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.